Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-
Go back to Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-| (NASDAQ: LQDA) | Delayed: 66.43 -0.45 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.88 | 52 Week High | $ | |||
| Open | $67.18 | 52 Week Low | $ | |||
| Day High | $67.41 | P/E | N/A | |||
| Day Low | $65.74 | EPS | $ | |||
| Volume | 1,010,233 | |||||
